PMID- 9356485 OWN - NLM STAT- MEDLINE DCOM- 19971216 LR - 20230331 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 94 IP - 23 DP - 1997 Nov 11 TI - ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk. PG - 12539-44 AB - Engagement of the mast cell high-affinity receptor for immunoglobulin E (IgE), FcepsilonRI, induces tyrosine phosphorylation of Syk, a non-receptor tyrosine kinase, that has been demonstrated as critical for degranulation. Herein we describe a synthetic compound, ER-27319, as a potent and selective inhibitor of antigen or anti-IgE-mediated degranulation of rodent and human mast cells. ER-27319 affected neither Lyn kinase activity nor the antigen-induced phosphorylation of the FcepsilonRI but did effectively inhibit the tyrosine phosphorylation of Syk and thus its activity. As a consequence, tyrosine phosphorylation of phospholipase C-gamma1, generation of inositol phosphates, release of arachidonic acid, and secretion of histamine and tumor necrosis factor alpha were also inhibited. ER-27319 did not inhibit the anti-CD3-induced tyrosine phosphorylation of phospholipase C-gamma1 in Jurkat T cells, demonstrating a specificity for Syk-induced signals. In contrast the tyrosine phosphorylation and activation of Syk, induced by in vitro incubation with the phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) of FcepsilonRI gamma subunit or by antigen activation of RBL-2H3 cells, was specifically inhibited by ER-27319. However, when ER-27319 was added to immunoprecipitated Syk, derived from activated cells, no effect was seen on Syk activity. ER-27319 did not inhibit the tyrosine phosphorylation of Syk induced by activation in the presence of Igbeta ITAM or the anti-IgM-induced phosphorylation of Syk in human peripheral B cells. Therefore, ER-27319 selectively interferes with the FcepsilonRI gamma phospho-ITAM activation of Syk in vitro and in intact cells. These results confirm the importance of Syk in FcepsilonRI-mediated responses in mast cells and demonstrate the mast cell selectivity and therapeutic potential of ER-27319 in the treatment of allergic disease. FAU - Moriya, K AU - Moriya K AD - Department of Drug Discovery, Tsukuba Research Laboratories, Eisai Company, Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 30026, Japan. FAU - Rivera, J AU - Rivera J FAU - Odom, S AU - Odom S FAU - Sakuma, Y AU - Sakuma Y FAU - Muramato, K AU - Muramato K FAU - Yoshiuchi, T AU - Yoshiuchi T FAU - Miyamoto, M AU - Miyamoto M FAU - Yamada, K AU - Yamada K LA - eng PT - Journal Article PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Acridines) RN - 0 (Allergens) RN - 0 (Enzyme Precursors) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Receptors, IgE) RN - 218W96J218 (ER 27319) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.2 (SYK protein, human) RN - EC 2.7.10.2 (Syk Kinase) SB - IM MH - Acridines/chemistry/*pharmacology MH - Allergens/immunology/pharmacology MH - Animals MH - Cell Degranulation/*drug effects MH - Cell Line MH - Enzyme Precursors/*immunology MH - Humans MH - Intracellular Signaling Peptides and Proteins MH - Mast Cells/*immunology MH - Protein-Tyrosine Kinases/*immunology MH - Receptors, IgE/*immunology MH - Signal Transduction/*drug effects/immunology MH - Syk Kinase PMC - PMC25030 EDAT- 1997/11/14 00:00 MHDA- 1997/11/14 00:01 PMCR- 1998/05/11 CRDT- 1997/11/14 00:00 PHST- 1997/11/14 00:00 [pubmed] PHST- 1997/11/14 00:01 [medline] PHST- 1997/11/14 00:00 [entrez] PHST- 1998/05/11 00:00 [pmc-release] AID - 2887 [pii] AID - 10.1073/pnas.94.23.12539 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12539-44. doi: 10.1073/pnas.94.23.12539.